JP2013515006A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515006A5
JP2013515006A5 JP2012544924A JP2012544924A JP2013515006A5 JP 2013515006 A5 JP2013515006 A5 JP 2013515006A5 JP 2012544924 A JP2012544924 A JP 2012544924A JP 2012544924 A JP2012544924 A JP 2012544924A JP 2013515006 A5 JP2013515006 A5 JP 2013515006A5
Authority
JP
Japan
Prior art keywords
dca
synthetic
pharmaceutical composition
weight
total amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012544924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013515006A (ja
JP6393023B2 (ja
Filing date
Publication date
Priority claimed from GB1008726A external-priority patent/GB2480632A/en
Application filed filed Critical
Publication of JP2013515006A publication Critical patent/JP2013515006A/ja
Publication of JP2013515006A5 publication Critical patent/JP2013515006A5/ja
Application granted granted Critical
Publication of JP6393023B2 publication Critical patent/JP6393023B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012544924A 2009-12-18 2010-12-17 デオキシコール酸の調製のための方法 Expired - Fee Related JP6393023B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US28813209P 2009-12-18 2009-12-18
US61/288,132 2009-12-18
US30200710P 2010-02-05 2010-02-05
US61/302,007 2010-02-05
US30381610P 2010-02-12 2010-02-12
US61/303,816 2010-02-12
GB1008726.0 2010-05-25
GB1008726A GB2480632A (en) 2010-05-25 2010-05-25 Preparation of 12-keto and 12-alpha-hydroxy steroids
US34868610P 2010-05-26 2010-05-26
US61/348,686 2010-05-26
PCT/US2010/061150 WO2011075701A2 (en) 2009-12-18 2010-12-17 Methods for the purification of deoxycholic acid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016161932A Division JP6568025B2 (ja) 2009-12-18 2016-08-22 デオキシコール酸の合成および精製のための方法

Publications (3)

Publication Number Publication Date
JP2013515006A JP2013515006A (ja) 2013-05-02
JP2013515006A5 true JP2013515006A5 (enExample) 2018-03-22
JP6393023B2 JP6393023B2 (ja) 2018-09-19

Family

ID=42341289

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012544924A Expired - Fee Related JP6393023B2 (ja) 2009-12-18 2010-12-17 デオキシコール酸の調製のための方法
JP2016161932A Expired - Fee Related JP6568025B2 (ja) 2009-12-18 2016-08-22 デオキシコール酸の合成および精製のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016161932A Expired - Fee Related JP6568025B2 (ja) 2009-12-18 2016-08-22 デオキシコール酸の合成および精製のための方法

Country Status (17)

Country Link
US (5) US20130137884A1 (enExample)
EP (2) EP2513132B9 (enExample)
JP (2) JP6393023B2 (enExample)
KR (3) KR102058420B1 (enExample)
CN (3) CN107011401A (enExample)
AU (1) AU2010330760B2 (enExample)
CA (1) CA2782478A1 (enExample)
EA (2) EA031768B1 (enExample)
ES (1) ES2575559T3 (enExample)
GB (1) GB2480632A (enExample)
IL (2) IL220225A0 (enExample)
MY (1) MY167891A (enExample)
NZ (1) NZ700195A (enExample)
PH (1) PH12012501233A1 (enExample)
SG (3) SG181768A1 (enExample)
WO (1) WO2011075701A2 (enExample)
ZA (1) ZA201204388B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
CA2827643C (en) 2011-02-18 2019-05-07 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
EP3138850B8 (en) * 2011-06-16 2019-09-11 Allergan Sales, LLC Compositions containing deoxycholic acid and 10% deionized water in ethanol, directed to the purification of deoxycholic acid
US20130102580A1 (en) * 2011-09-22 2013-04-25 Kythera Biopharmaceuticals, Inc. Compositions and methods related to deoxycholic acid and its polymorphs
WO2013044119A1 (en) * 2011-09-22 2013-03-28 Kythera Biopharmaceuticals, Inc. Compositions and methods related to deoxycholic acid and its polymorphs
CN104447929B (zh) * 2014-10-28 2016-06-29 湖南科瑞生物制药股份有限公司 一种合成3-羰基-4-雄烯-17β羧酸的方法
CN106146593B (zh) * 2015-04-14 2021-06-01 南京迈诺威医药科技有限公司 一种制备去氧胆酸的方法
CN106046093A (zh) * 2016-05-30 2016-10-26 华东师范大学 一种石胆酸的合成方法
KR102527103B1 (ko) * 2016-06-06 2023-04-28 크리스탈 파마 에스.에이.유. 디옥시콜린산 제조방법 및 디옥시콜린산의 제조에 유용한 중간물
JP2019509333A (ja) * 2016-08-11 2019-04-04 サムスン ライフ パブリック ウェルフェア ファウンデーションSamsung Life Public Welfare Foundation デオキシコール酸を有効成分に含む脱毛の予防、改善、または治療用組成物
US11161872B2 (en) 2017-08-03 2021-11-02 Medytox Inc. Methods for preparing bile acids
JP6899529B2 (ja) 2017-08-10 2021-07-07 パナソニックIpマネジメント株式会社 冷凍サイクル用作動媒体および冷凍サイクルシステム
CN114478676B (zh) * 2022-02-18 2024-05-10 国药集团化学试剂有限公司 一种脱氧胆酸钠的制备方法
CN116444597B (zh) * 2023-03-30 2025-03-28 南京迈诺威医药科技有限公司 一种制备去氧胆酸中间体和去氧胆酸的方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US53446A (en) 1866-03-27 Improvement in cultivators
US2321598A (en) 1940-10-07 1943-06-15 George A Breon & Company Inc Preparation of desoxycholic acid
US2509248A (en) * 1947-09-05 1950-05-30 Merck & Co Inc Process for producing delta9, 11-3(alpha)-hydroxy-17-ketoetiocholene
GB695504A (en) 1950-10-18 1953-08-12 Drug Res Inc Method of isolating and purifying cholic and desoxycholic acids
GB716670A (en) 1951-06-19 1954-10-13 Armour & Co Improved process for purifying desoxycholic acid from contaminating cholic acid
US2651643A (en) * 1951-06-19 1953-09-08 Armour & Co Purification of desoxycholic acid
US2891972A (en) 1952-08-19 1959-06-23 Drug Res Inc Process of separating desoxycholic acid from mixed crude bile acids or salts thereof
US3533908A (en) 1967-05-19 1970-10-13 Brown Co Porous paperboard sheet having plastic microspheres therein
IT1202370B (it) 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
FR2446293A1 (fr) 1978-12-11 1980-08-08 Roussel Uclaf Procede de purification de l'acide chenodesoxycholique
IT8167097A0 (it) 1981-01-26 1981-01-26 Unilever Nv Composizione cosmetica per il trattamento della pelle o dei capelli
AU618350B2 (en) 1988-04-08 1991-12-19 Aventis Pharma S.A. 9-alpha-hydroxy-17-methylene steroids, process for their preparation and their use in the preparation of corticosteroids
US5085864A (en) 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
CA2033725C (en) 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
AU4613296A (en) 1994-07-25 1996-04-19 Nda International, Inc. A method of treating chemical dependency in mammals and a composition therefor
US20020107291A1 (en) 1997-05-26 2002-08-08 Vincenzo De Tommaso Clear, injectable formulation of an anesthetic compound
IL123998A (en) 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
US6417179B1 (en) 1998-10-13 2002-07-09 Craig G. Burkhart Ear wax solution
CA2362917C (en) * 1999-02-12 2003-08-05 Compass Pharmaceuticals, Llc Methods for anti-tumor therapy
JP2004500378A (ja) 2000-02-04 2004-01-08 ヨー、セオ、ホン 胆汁酸を含有する清浄水溶液製型の製造
NZ546612A (en) 2001-05-22 2007-08-31 Inflazyme Pharm Ltd Process for the production of 6,7-dihydroxy steroid compounds by allylic oxidation of steroid-5-ene compounds to steroid-5-ene-7-one compounds followed by hydroboration and oxidation intermediates of this process
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ES2372499T3 (es) 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
US20060222695A1 (en) 2005-04-01 2006-10-05 Filiberto Zadini Deoxycholic acid liposome-based dermatological topical preparation
CN101148468A (zh) 2006-09-19 2008-03-26 天津科技大学 以动物胆汁为原料高效提取胆红素和胆汁酸技术
WO2008091540A2 (en) * 2007-01-19 2008-07-31 Intercept Pharmaceuticals, Inc. 23-substituted bile acids as tgr5 modulators and methods of use thereof
JO3172B1 (ar) * 2007-06-19 2018-03-08 Kythera Biopharmaceuticals Inc تركيبة وطريقة وتحضير الصفراء الصناعية
US20080318870A1 (en) 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
JOP20180077A1 (ar) * 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
PL2300489T3 (pl) * 2008-06-06 2016-11-30 Sposoby wytwarzania 17-alkinylo-7-hydroksysteroidów i związków pokrewnych
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
EP3138850B8 (en) 2011-06-16 2019-09-11 Allergan Sales, LLC Compositions containing deoxycholic acid and 10% deionized water in ethanol, directed to the purification of deoxycholic acid
US20130102580A1 (en) 2011-09-22 2013-04-25 Kythera Biopharmaceuticals, Inc. Compositions and methods related to deoxycholic acid and its polymorphs

Similar Documents

Publication Publication Date Title
JP2013515006A5 (enExample)
JP2011518833A5 (enExample)
JP2013515822A5 (enExample)
JP2019048894A5 (enExample)
JP2011207901A5 (enExample)
JP2013525444A5 (enExample)
EP4643945A3 (en) Neuroactive steroids and methods of use thereof
JP2009149903A5 (enExample)
JP2007327074A5 (enExample)
JP2010530373A5 (enExample)
JP2014221842A5 (enExample)
ECSP13012668A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
JP2012531470A5 (enExample)
JP2013532130A5 (enExample)
JP2014506907A5 (enExample)
JP2014235432A5 (enExample)
JP2012233166A5 (enExample)
PH12017501029B1 (en) Biaryl derivative as gpr120 agonist
JP2014507455A5 (enExample)
CN103717571B8 (zh) 9‑氨基甲基取代的四环素类化合物
JP2010508310A5 (enExample)
JP2013543253A5 (enExample)
JP2014528494A5 (enExample)
JP2014530818A5 (enExample)
NZ600263A (en) 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof